State Of Wisconsin Investment Board Allogene Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

$36.9 Billion
Q4 2024

A detailed history of State Of Wisconsin Investment Board transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 14,919 shares of ALLO stock, worth $21,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,919

Previous 12,870 15.92%

Holding current value

$21,632

Previous $36,000 13.89%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.84 - $3.22 $3,770 - $6,597	2,049 Added 15.92%	14,919 $31,000
Q2 2024 Aug 14, 2024	BUY	$2.23 - $4.38 $28,700 - $56,370	12,870 New	12,870 $29,000
Q4 2023 Feb 12, 2024	SELL	$2.28 - $3.5 $363,247 - $557,616	-159,319 Reduced 86.1%	25,729 $82,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $5.96 $346,306 - $651,100	109,245 Added 144.12%	185,048 $586,000
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $18,396 - $27,371	-4,061 Reduced 5.08%	75,803 $376,000
Q1 2023 May 15, 2023	SELL	$4.92 - $8.21 $12,295 - $20,516	-2,499 Reduced 3.03%	79,864 $394,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $29,679 - $58,671	-5,281 Reduced 6.03%	82,363 $518,000
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $715,351 - $1.2 Million	-69,317 Reduced 44.16%	87,644 $947,000
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $66,179 - $119,865	9,761 Added 6.63%	156,961 $1.79 Million
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $452,880 - $905,168	59,200 Added 67.27%	147,200 $1.34 Million
Q2 2021 Aug 12, 2021	BUY	$23.49 - $35.8 $364,095 - $554,900	15,500 Added 21.38%	88,000 $2.3 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $79,949 - $120,962	-3,100 Reduced 4.1%	72,500 $2.56 Million
Q4 2020 Feb 03, 2021	SELL	$25.24 - $43.45 $58,052 - $99,935	-2,300 Reduced 2.95%	75,600 $1.91 Million
Q2 2020 Aug 12, 2020	BUY	$18.39 - $54.04 $331,020 - $972,720	18,000 Added 30.05%	77,900 $3.34 Million
Q1 2020 May 06, 2020	BUY	$18.22 - $28.25 $30,973 - $48,025	1,700 Added 2.92%	59,900 $1.16 Million
Q3 2019 Nov 12, 2019	BUY	$26.11 - $32.99 $684,082 - $864,338	26,200 Added 81.88%	58,200 $1.59 Million
Q2 2019 Aug 14, 2019	BUY	$25.56 - $31.09 $817,920 - $994,880	32,000 New	32,000 $859,000

Others Institutions Holding ALLO

# of Institutions

178

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $209M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Allogene Therapeutics, Inc. Transaction History